Electromed, Inc. (NYSE:ELMD) Director Andrew Summers Sells 50,751 Shares of Stock

Electromed, Inc. (NYSE:ELMD) Director Andrew Summers sold 50,751 shares of the stock in a transaction on Monday, February 24th. The stock was sold at an average price of $27.30, for a total value of $1,385,502.30. Following the completion of the sale, the director now owns 65,714 shares in the company, valued at $1,793,992.20. This trade represents a 43.58 % decrease in their position. The sale was disclosed in a filing with the SEC, which can be accessed through this hyperlink.

Andrew Summers also recently made the following trade(s):

• On Thursday, February 20th, Andrew Summers sold 35,273 shares of Electromed stock. The stock was sold at an average price of $28.83, for a total value of $1,016,920.59.
• On Wednesday, December 4th, Andrew Summers sold 12,731 shares of Electromed stock. The shares were sold at an average price of $29.98, for a total value of $381,675.38.
• On Monday, December 2nd, Andrew Summers sold 17,463 shares of Electromed stock. The stock was sold at an average price of $30.09, for a total value of $525,461.67.

Electromed Stock Down 3.6 %

Shares of ELMD stock opened at $26.97 on Tuesday. The business has a 50-day moving average price of $31.37 and a two-hundred day moving average price of $25.49. Electromed, Inc. has a 12-month low of $13.74 and a 12-month high of $35.56. The firm has a market cap of $230.78 million, a P/E ratio of 35.96 and a beta of 0.33.

Institutional Trading of Electromed

Hedge funds have recently bought and sold shares of the company. Arrowstreet Capital Limited Partnership grew its position in Electromed by 261.0% during the fourth quarter. Arrowstreet Capital Limited Partnership now owns 114,579 shares of the company’s stock valued at $3,386,000 after acquiring an additional 82,839 shares during the last quarter. Raymond James Financial Inc. bought a new position in shares of Electromed during the 4th quarter valued at $1,760,000. Sowell Financial Services LLC purchased a new position in Electromed in the 4th quarter worth $1,518,000. Lazard Asset Management LLC lifted its stake in Electromed by 19,860.8% in the fourth quarter. Lazard Asset Management LLC now owns 47,906 shares of the company’s stock worth $1,415,000 after purchasing an additional 47,666 shares during the last quarter. Finally, Two Sigma Investments LP purchased a new stake in Electromed during the fourth quarter valued at about $1,255,000. Institutional investors own 40.82% of the company’s stock.

Wall Street Analyst Weigh In

Several equities research analysts have issued reports on ELMD shares. B. Riley initiated coverage on shares of Electromed in a research report on Thursday, February 20th. They set a “buy” rating and a $38.00 target price for the company. StockNews.com downgraded shares of Electromed from a “strong-buy” rating to a “buy” rating in a report on Wednesday, February 19th.

About Electromed

Electromed, Inc develops, manufactures, markets, and sells airway clearance therapy and related products that apply high frequency chest wall oscillation (HFCWO) therapy in pulmonary care for patients of various ages in the United States and internationally. The company offers SmartVest airway clearance system for patients with compromised pulmonary functions, including bronchiectasis and cystic fibrosis, as well as neuromuscular conditions, such as cerebral palsy and amyotrophic lateral sclerosis; SmartVest SQL System; SmartVest Clearway System that consists of an inflatable therapy garment, a programmable air pulse generator, and a patented single-hose that delivers air pulses from the generator to the garment to create oscillatory pressure on the chest wall; and SmartVest Connect, a wireless technology that allows data connection between physicians and patients to track therapy performance and collaborate in treatment decisions.